Feb 11, 2026 04:01PM
Feb 11, 2026 04:01PM
Feb 4, 2026 04:01PM
Jan 9, 2026 06:01PM
Jan 8, 2026 08:49AM
Nov 16, 2025 03:00PM
Nov 13, 2025 04:04AM Goldman Sachs on Ascendis Pharma (ASND): 'in transition to profitability'
Nov 12, 2025 04:05PM
Nov 12, 2025 04:01PM
Nov 5, 2025 04:01PM
Oct 12, 2025 03:00PM
Sep 15, 2025 11:50AM
Aug 8, 2025 05:29AM
Aug 7, 2025 04:04PM Ascendis Pharma (ASND) Tops Q2 EPS by 45c
Aug 7, 2025 04:01PM
Jul 31, 2025 04:01PM
Jun 10, 2025 06:32AM
May 25, 2025 03:00PM
May 1, 2025 04:01PM
May 1, 2025 04:01PM
Apr 24, 2025 04:01PM Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
Apr 2, 2025 07:04AM
Feb 25, 2025 09:24AM
Feb 15, 2025 10:00PM
Feb 12, 2025 04:01PM
Feb 11, 2025 06:48AM
Feb 5, 2025 04:01PM
Nov 15, 2024 07:10AM Ascendis Pharma (ASND) PT Lowered to $200 at Citi
Nov 14, 2024 04:04PM
Nov 14, 2024 04:01PM
Nov 7, 2024 04:01PM
Oct 21, 2024 08:26AM
Sep 4, 2024 04:57AM
Sep 3, 2024 05:15PM
Sep 3, 2024 05:04PM Ascendis Pharma Reports Second Quarter 2024 Financial Results
Aug 28, 2024 08:30AM
Aug 21, 2024 06:21AM
May 2, 2024 04:01PM
Apr 25, 2024 04:46PM
Feb 7, 2024 04:47PM
Feb 7, 2024 04:01PM
Jan 31, 2024 04:15PM Ascendis Pharma to Report Full Year 2023 Financial Results and Provide Business Update on February 7, 2024
Jan 8, 2024 05:23AM
Jan 7, 2024 05:45PM
Nov 16, 2023 09:00AM
Nov 7, 2023 04:25PM
Nov 7, 2023 04:01PM
Oct 31, 2023 08:30AM
Sep 5, 2023 04:04PM Ascendis Pharma (ASND) Tops Q2 EPS by EUR 37c, Beats on Revenue; Offers FY23 Revenue Guidance
Sep 5, 2023 04:03PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All